Christiana Goh Bardon
SB/SM '93, Massachusetts Institute of Technology
Chestnut Hill, Massachusetts
Educated as a physician-scientist, Christiana Goh Bardon works at the crossroads of biotechnology, medicine, and finance to propel breakthroughs in the treatment and cure of disease.
Bardon is a portfolio manager of Burrage Capital Fund and the Oncology Impact Fund—both dedicated investments in drug development for unmet medical needs, with an emphasis on cancer. Her firm has also created impact-investing initiatives to support next-generation basic science research and expand cancer care in developing countries.
A proud immigrant who came to the U.S. when she was four, Bardon went on to receive two degrees from MIT. Motivated by a relative’s battle with lung cancer, she earned her MD from Harvard Medical School (HMS), where she was a Howard Hughes Medical Institute Fellow. She completed her residency at Brigham and Women’s Hospital before pursuing her MBA at Harvard Business School.
She is a trustee of the American Association for Cancer Research Foundation, one of the world’s largest organizations dedicated to cancer research. She also serves on the HMS Board of Fellows and has been active in educational initiatives.
“My education at Harvard transformed my life and taught me invaluable lessons in empathy, integrity, leadership, and teamwork. My career in medicine and biotechnology has been focused on the pursuit of scientific expertise and its application to real-world problems. My personal experiences as a first-generation immigrant from a family of entrepreneurs have broadened my perspectives. I would be honored to bring these experiences to the work of the Overseers.”